Utility of NT-pro-BNP in patients undergoing transapical aortic valve replacement

Clinical Research in Cardiology

Volumn 99, Issue 5, 2010, Pages 301-307

  Pfister, Roman ^a   Wahlers, Thorsten ^a   Baer, Frank M ^a   Scherner, Max ^a   Strauch, Justus ^a   Erdmann, Erland ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

NT pro BNP; Prognosis; Trans apical aortic valve replacement

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE;

AGED; AORTA STENOSIS; AORTA VALVE; AORTA VALVE REPLACEMENT; ARTICLE; CLINICAL ARTICLE; DISEASE CLASSIFICATION; FEMALE; FUNCTIONAL STATUS; HEART LEFT VENTRICLE MASS; HUMAN; MALE; MORTALITY; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PILOT STUDY; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; SCORING SYSTEM; TRANSAPICAL AORTIC VALVE REPLACEMENT;

AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; FEMALE; HEART VALVE PROSTHESIS; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 77954659815     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-010-0118-x     Document Type: Article

References (25)

1. Antonini-Canterin F, Popescu BA, Popescu AC, Beladan CC, Korcova R, Piazza R, Cappelletti P, Rubin D, Cassin M, Faggiano P, Nicolosi GL (2008) Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement. Int J Cardiol 128:406-412
2. Bergler-Klein J, Klaar U, Heger M, Rosenhek R, Mundigler G, Gabriel H, Binder T, Pacher R, Maurer G, Baumgartner H (2004) Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 109:2302-2308
3. Bergler-Klein J, Mundigler G, Pibarot P, Burwash IG, Dumesnil JG, Blais C, Fuchs C, Mohty D, Beanlands RS, Hachicha Z, Walter-Publig N, Rader F, Baumgartner H (2007) B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study. Circulation 115:2848-2855
4. Bleiziffer S, Ruge H, Mazzitelli D, Schreiber C, Hutter A, Laborde JC, Bauernschmitt R, Lange R (2009) Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team. Eur J Cardiothorac Surg 35:615-620
5. Cemri M, Arslan U, Kocaman SA, Cengel A (2008) Relationship between N-terminal pro-B type natriuretic peptide and extensive echocardiographic parameters in mild to moderate aortic stenosis. J Postgrad Med 54:12-16
6. Georges A, Forestier F, Valli N, Plogin A, Janvier G, Bordenave L (2004) Changes in type B natriuretic peptide (BNP) concentrations during cardiac valve replacement. Eur J Cardiothorac Surg 25:941-945
7. Gerber IL, Legget ME, West TM, Richards AM, Stewart RA (2005) Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration. Am J Cardiol 95:898-901
8. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A (2003) A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24:1231-1243
9. Krayenbuehl HP, Hess OM, Monrad ES, Schneider J, Mall G, Turina M (1989) Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 79:744-755
10. Kurz K, Voelker R, Zdunek D, Wergeland R, Hess G, Ivandic B, Katus H, Giannitsis E (2007) Effect of stress-induced reversible ischemia on serum concentrations of ischemia-modified albumin, natriuretic peptides and placental growth factor. Clin Res Cardiol 96:152-159
11. Lim P, Monin JL, Monchi M, Garot J, Pasquet A, Hittinger L, Vanoverschelde JL, Carayon A, Gueret P (2004) Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. Eur Heart J 25:2048-2053
12. Nessmith MG, Fukuta H, Brucks S, Little WC (2005) Usefulness of an elevated B-type natriuretic peptide in predicting survival in patients with aortic stenosis treated without surgery. Am J Cardiol 96:1445-1448
13. Neverdal NO, Knudsen CW, Husebye T, Vengen OA, Pepper J, Lie M, Tonnessen T (2006) The effect of aortic valve replacement on plasma B-type natriuretic peptide in patients with severe aortic stenosis-1-year follow-up. Eur J Heart Fail 8:257-262
14. Orlowska-Baranowska E, Baranowski R, Greszata L, Stepinska J (2008) Brain natriuretic peptide as a marker of left ventricular hypertrophy in patients with aortic stenosis. J Heart Valve Dis 17:598-605
15. Pedrazzini GB, Masson S, Latini R, Klersy C, Rossi MG, Pasotti E, Faletra FF, Siclari F, Minervini F, Moccetti T, Auricchio A (2008) Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis. Am J Cardiol 102:749-754
16. Pfister R, Scholz M, Wielckens K, Erdmann E, Schneider CA (2004) Use of NT-proBNP in routine testing and comparison to BNP. Eur J Heart Fail 6:289-293
17. Pfister R, Tan D, Thekkanal J, Hellmich M, Erdmann E, Schneider CA (2007) NT-pro-BNP measured at discharge predicts outcome in multimorbid diabetic inpatients with a broad spectrum of cardiovascular disease. Acta Diabetol 44:91-97
18. Pfister R, Tan D, Thekkanal J, Hellmich M, Schneider CA (2007) NT-pro-BNP is associated with long-term outcome in a heterogeneous sample of cardiac inpatients. Eur J Intern Med 18:215-220
19. Scharhag J, Herrmann M, Weissinger M, Herrmann W, Kindermann W (2007) N-terminal B-type natriuretic peptide concentrations are similarly increased by 30 minutes of moderate and brisk walking in patients with coronary artery disease. Clin Res Cardiol 96:218-226
20. Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, Cribier A, De Jaegere P, Fournial G, Kappetein AP, Kovac J, Ludgate S, Maisano F, Moat N, Mohr F, Nataf P, Pierard L, Pomar JL, Schofer J, Tornos P, Tuzcu M, van Hout HB, Von Segesser LK, Walther T (2008) Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 29:1463-1470
21. van Kimmenade RR, Januzzi JL Jr, Bakker JA, Houben AJ, Rennenberg R, Kroon AA, Crijns HJ, van Dieijen-Visser MP, de Leeuw PW, Pinto YM (2009) Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects. J Am Coll Cardiol 53:884-890
22. Vanderheyden M, Goethals M, Verstreken S, DeBruyne B, Muller K, VanSchuerbeeck E, Bartunek J (2004) Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. J Am Coll Cardiol 44:2349-2354
23. Walther T, Simon P, Dewey T, Wimmer-Greinecker G, Falk V, Kasimir MT, Doss M, Borger MA, Schuler G, Glogar D, Fehske W, Wolner E, Mohr FW, Mack M (2007) Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 116:I240-I245 (Pubitemid 47480797)
24. Weber M, Arnold R, Rau M, Brandt R, Berkovitsch A, Mitrovic V, Hamm C (2004) Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. Am J Cardiol 94:740-745
25. Weber M, Arnold R, Rau M, Elsaesser A, Brandt R, Mitrovic V, Hamm C (2005) Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J 26:1023-1030